News

ATI's 64% YTD rally is powered by surging aerospace and defense demand, a record $4.4B backlog, wider margins and a raised 2026 outlook.

CNC, ATI and SANM made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 10, 2026.

Howmet Aerospace (HWM) has fallen about 21% from its August high, and the question is whether that is a gift or a warning. Its own record says falls this size have paid off more often than not, and that you will probably watch it fall further first. What knocked the stock down is a scare about who else might make turbine blades. Start with what the record paid.

CNC, NESR and ATI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 8, 2026.

BMA, ATI, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 4, 2026.

BMA, ATI, and SANM it to the Zacks Rank #1 (Strong Buy) growth stocks list on September 1, 2026.

ATI shares have surged nearly 28% in three months as record backlog, aerospace demand, capacity expansion and higher 2026 guidance fuel momentum.

Whether you see them or not, industrials businesses play a crucial part in our daily activities. Still, their generally high capital requirements expose them to the ups and downs of economic cycles, and the market seems to be baking in a prolonged downturn as the industry has shed 1.5% over the past six months. This performance is a stark contrast from the S&P 500’s 10.9% gain.

According to the average brokerage recommendation (ABR), one should invest in ATI (ATI). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

ATI Inc. has reported past second-quarter 2026 results showing sales of US$1,261.1 million and net income of US$151 million, alongside continued execution of its share repurchase program totaling US$705.12 million since 2024. The combination of higher year-on-year earnings per share and ongoing buybacks suggests ATI is simultaneously improving profitability and reducing its share count, which can enhance per-share financial metrics. We’ll now examine how ATI’s stronger quarterly earnings and...

CNC, ATI and MNDY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 18, 2026

Bank of America, Mettler-Toledo and VSE post strong gains as Zacks' Focus List, ECAP and Top 10 picks outperform.

ATI's Q2 earnings surge on strong aerospace and defense demand, record backlog and pricing gains, prompting higher 2026 guidance.

Does ATI (ATI) have what it takes to be a top stock pick for momentum investors? Let's find out.

3D Printing is reshaping industries with faster production and lower costs, drawing investor interest. Stocks like PRLB, SSYS, AME, ATRI and CRS offer strong growth potential.

Howmet is the Big Cap 20 component in focus as the stock tests a key level after breaking out in June. The stock is wading in a 5% buy zone, rendering it actionable now. Both Howmet and fellow aerospace stock ATI reported robust earnings, causing several of these names to rally in unison.

Aerospace, defense plays rally on earnings wave. Howmet, ATI score breakouts. Redwire, CACI International make bullish moves.

Specialty materials manufacturer ATI (NYSE:ATI) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 10.6% year on year to $1.26 billion. Its non-GAAP profit of $1.23 per share was 18.3% above analysts’ consensus estimates.

In the most recent trading session, ATI (ATI) closed at $181.9, indicating a +2.24% shift from the previous trading day.

In recent days ATI has drawn attention ahead of its 6 August 2026 earnings release, as analysts now expect materially higher year-over-year EPS and revenue and have been revising estimates upward. This optimism, reflected in ATI’s Zacks Rank #2 (Buy) and strong average broker recommendations, has coincided with ongoing strength in its recent price trend. ATI’s growing appeal to analysts, highlighted by positive estimate revisions and strong broker ratings ahead of earnings, suggests that...

High temperature metals maker ATI entered a buy range as analysts look out for accelerated earnings growth on Aug. 6.

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.

In the latest trading session, ATI (ATI) closed at $193.59, marking a +2.19% move from the previous day.

ATI (ATI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

ATI's 72% YTD rally is fueled by aerospace, defense and specialty energy demand, capacity investments, earnings beats and a stronger growth outlook.

Here is how ATI (ATI) and Leonardo DRS, Inc. (DRS) have performed compared to their sector so far this year.

Recently, ATI reported continued momentum in its aerospace and defense-focused specialty materials business, highlighting multi-year revenue growth, stronger free cash flow margins, and the impact of share repurchases on earnings per share. What stands out is how ATI’s advanced metallurgy capabilities and disciplined capital allocation are helping it deepen its role in high-performance applications across aerospace, defense, and energy transition markets. We’ll now examine how ATI’s...

ATI (ATI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.